ramatroban has been researched along with 11-dehydro-thromboxane b2 in 1 studies
| Studies (ramatroban) | Trials (ramatroban) | Recent Studies (post-2010) (ramatroban) | Studies (11-dehydro-thromboxane b2) | Trials (11-dehydro-thromboxane b2) | Recent Studies (post-2010) (11-dehydro-thromboxane b2) |
|---|---|---|---|---|---|
| 142 | 10 | 28 | 380 | 89 | 89 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, E; Heinemann, A; Kollroser, M; McNamee, A; Pease, JE; Peskar, BA; Sandig, H; Shichijo, M; Sturm, GJ; Weiglhofer, I | 1 |
1 other study(ies) available for ramatroban and 11-dehydro-thromboxane b2
| Article | Year |
|---|---|
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Basophils; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Carbazoles; Cell Size; Chemotaxis, Leukocyte; Enzyme Inhibitors; Eosinophils; Fatty Acids, Unsaturated; Flow Cytometry; Humans; Hydrazines; Pertussis Toxin; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; Sulfonamides; Thromboxane B2; Transfection; Type C Phospholipases | 2004 |